Acquisition by Camela Wisel of 5425 shares of Chemours subject to Rule 16b-3
| CC Stock | MXN 385.07 0.00 0.00% |
Slightly above 55% of Chemours' investor base is interested to short. The analysis of current outlook of investing in The Chemours suggests that many traders are impartial regarding Chemours' prospects. Chemours' investing sentiment can be driven by a variety of factors including economic data, Chemours' earnings reports, geopolitical events, and overall market trends.
Chemours |
Filed transaction by Chemours Co officer. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Chemours Fundamental Analysis
We analyze Chemours' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemours using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemours based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Chemours is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Chemours Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Chemours stock to make a market-neutral strategy. Peer analysis of Chemours could also be used in its relative valuation, which is a method of valuing Chemours by comparing valuation metrics with similar companies.
Peers
Chemours Related Equities
| DBN | Deutsche Bank | 1.50 | ||||
| MU | Micron Technology | 0.40 | ||||
| DXC | DXC Technology | 0.00 | ||||
| AMAT | Applied Materials | 0.27 | ||||
| GMXT | GMxico Transportes | 0.38 | ||||
| BNS | Bank of Nova Scotia | 3.50 | ||||
| X | United States | 6.56 |
Additional Tools for Chemours Stock Analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.